Clinical trial
Intradermal Quadrivalent Influenza Vaccine With Topical Imiquimod in Elderly & Chronic Ill Subjects, a Double-Blind Randomized Controlled Trial
NCT04143451 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intradermal Quadrivalent Influenza Vaccine With Topical Imiquimod in Elderly & Chronic Ill Subjects, a Double-Blind Randomized Controlled Trial
- Lead sponsor
- The University of Hong Kong
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- October 23, 2019
- Completion date
- March 31, 2023
- Enrollment
- 4,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza